October 20, 2017
Pharma companies were fairly active in digital health in the third quarter of 2017, especially in the areas of diabetes and respiratory disease. Read on for a round-up of notable events.
Abbott Diabetes Care had a big quarter for its Freestyle Libre system, both in the United States and abroad. First, in July, Abbott and Bigfoot Biomedical entered into an agreement to develop...
September 6, 2017
Truveris, a healthcare technology company focused cloud-based data analytics solutions for the $450 billion prescription benefits industry, today announced that the company has secured $25 million in a new round of funding to accelerate its growth strategies.
The Series D round was led by McKesson Ventures, and included Canaan Partners, New Leaf Venture Partners, Tribeca Venture Partners, and...
August 23, 2017
Precision medicine company GNS Healthcare has raised an additional $6 million in equity from Amgen Ventures, with participation from existing investor Alexandria Real Estate Equities. The funds will be used to further develop the company's REFS causal machine learning and simulation platform -- as well as solutions across drug discovery and development, value-based drug solutions, and care...
July 14, 2017
In Q2 2017, we continued to see more pharma companies step up their efforts in digital health, from app launches to FDA clearances to wearable usage in clinical trials. Read on below for a summary of those moves.
In a move that could have growing significance for pharma going forward, the Clinical Trials Transformation Initiative (CTTI), a public-private partnership of pharma companies, academics...
April 20, 2017
Digital specialty prescribing platform ZappRx has raised $25 million in Series B funding in a round led by Qiming US Healthcare Fund. GV, formerly Google Ventures, and SR One also contributed funding.
ZappRx’s cloud-based platform serves as a conduit for providers, pharmacies and patients to collaborate on the prescribing and management of specialty medications, which are used for complex...
April 19, 2017
The first quarter of 2017 saw pharma’s visible participation in digital health steadily ramping up. From partnerships that augment digital diabetes care to infant sleep coaching collaborations, we've covered quite a range of pharma-focused news in Q1. Read on for our list of the digital undertakings of Roche, Takeda, UCB, Johnson & Johnson, and many more.
Boehringer Ingelheim partnered with...
January 13, 2017
In 2016, we rounded up pharma news in the first, second, and third quarter of the year. Pharma news in the fourth quarter of 2016 mostly fit into two buckets: clinical trial data collection and chronic condition management. The latter focused especially on the diabetes and chronic respiratory disease spaces. Read on below for Q4 2016 news from a number of pharma companies from around the world....
November 28, 2016
By: Jennifer Plumer, Director of Market Development, Validic
So you’ve decided to include digital health devices in your trial. While that’s a great step to take as an organization, and an important step towards innovating the R&D process, it’s just the beginning.
You now have to select a device that will best suit the needs of both the trial and the patient and think through nuances with...
October 7, 2016
We've come to the end of the third quarter, so we at MobiHealthNews have looked into our archives and rounded up the major stories of the quarter for the hospital, pharma, and insurance sectors. Read on for provider, pharma, and payer news.
The third quarter of 2016 has provided a steady stream of provider news. From partnerships that blend traditional healthcare systems with digital...
June 23, 2016
Larry Brooks, director of business innovation at Boehringer Ingelheim, took the stage in a fireside chat with Medullan EVP and Managing Director Jonathan Chen at MobiHealthNews 2016 in San Francisco last week. Brooks has been leading Boehringer's digital health group for the past five years, and he shed some light on how the pharma company's approach to the space has changed during that time.